We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Raps Nostrum Laboratories for Failure to Investigate Low Bottle Counts
FDA Raps Nostrum Laboratories for Failure to Investigate Low Bottle Counts
An FDA inspection of Nostrum Laboratories’ Lenexa, Kansas facility found that it failed to properly identify and track bottles containing low pill counts after the company received complaints earlier in the year.